A novel SPECT/CT acquisition method can accurately detect radiopharmaceutical biodistribution in a convenient manner for prostate cancer patients, opening the door for more personalized treatment.
Many people have experienced a scan in the nuclear medicine department of a hospital or clinic. It may seem a straightforward procedure for the patient, but the technology involved is a complex ...
U-SPECT 7 CT from MILabs (a Rigaku company) offers unmatched preclinical dynamic and whole-body Single Photon Emission Computed Tomography (SPECT) performance, integrated with diagnostic micro-CT.
Press releases are posted on Independent.com as a free community service. Santa Barbara, CA- Since 2020, the Cancer Foundation of Santa Barbara has invested more than $10M into the Nuclear Medicine ...
Preclinical imaging is rapidly becoming a standard technology for drug discovery and development. This adoption has been driven by the increasing pressure on pharmaceutical companies to identify ways ...
HAMBURG, Germany, Oct. 21, 2024 /PRNewswire/ -- Mediso is unveiling its new AnyScan® TRIO SPECT/CT, TheraMAX* scanner at the annual meeting of European Association of Nuclear Medicine (EANM). The ...
New heart imaging technology to diagnose coronary heart disease and other heart disorders is significantly more accurate, less expensive and safer than traditional methods, according to a new study by ...
HEIDELBERG, Germany, Oct. 3, 2025 /PRNewswire/ -- Mediso completes the installation of an AnyScan® TRIO-TheraMAX SPECT/CT at the Department of Nuclear Medicine at Heidelberg University Hospital.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results